Source:http://linkedlifedata.com/resource/pubmed/id/16837570
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2006-9-21
|
pubmed:abstractText |
Hydrolase activity from human liver and small intestine microsomes was compared with that of recombinant human carboxylesterases, hCE-1 and hCE-2. Although both hCE-1 and hCE-2 are present in human liver, the dominant component was found to be hCE-1, whereas the hydrolase activity of the human small intestine was found to be predominantly hCE-2. hCE-2 has a limited ability to hydrolyze large acyl compound substrates. Interestingly, propranolol derivatives, good substrates for hCE-2, were easily hydrolyzed by substitution of the methyl group on the 2-position of the acyl moiety, but were barely hydrolyzed when the methyl group was substituted on the 3-position. These findings suggest that hCE-2 does not easily form acylated intermediates because of conformational interference in its active site. In contrast, hCE-1 could hydrolyze a variety of substrates. The hydrolytic activity of hCE-2 increased with increasing alcohol chain length in benzoic acid derivative substrates, whereas hCE-1 preferentially catalyzed the hydrolysis of substrates with short alcohol chains. Kinetic data showed that the determining factor for the rate of hydrolysis of p-aminobenzoic acid esters was V(max) for hCE-1 and K(m) for hCE-2. Furthermore, the addition of hydrophobic alcohols to the reaction mixture with p-aminobenzoic acid propyl ester induced high and low levels of transesterification by hCE-1 and hCE-2, respectively. When considering the substrate specificities of hCE-1, it is necessary to consider the transesterification ability of hCE-1, in addition to the binding structure of the substrate in the active site of the enzyme.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Benzoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/CES1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/CES2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Carboxylesterase,
http://linkedlifedata.com/resource/pubmed/chemical/Carboxylic Ester Hydrolases,
http://linkedlifedata.com/resource/pubmed/chemical/Flurbiprofen,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrolases,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Propranolol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0090-9556
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1734-41
|
pubmed:dateRevised |
2010-5-20
|
pubmed:meshHeading |
pubmed-meshheading:16837570-Animals,
pubmed-meshheading:16837570-Benzoic Acids,
pubmed-meshheading:16837570-Carboxylesterase,
pubmed-meshheading:16837570-Carboxylic Ester Hydrolases,
pubmed-meshheading:16837570-Cell Line,
pubmed-meshheading:16837570-Flurbiprofen,
pubmed-meshheading:16837570-Humans,
pubmed-meshheading:16837570-Hydrolases,
pubmed-meshheading:16837570-Hydrolysis,
pubmed-meshheading:16837570-Intestine, Small,
pubmed-meshheading:16837570-Isoenzymes,
pubmed-meshheading:16837570-Liver,
pubmed-meshheading:16837570-Microsomes,
pubmed-meshheading:16837570-Microsomes, Liver,
pubmed-meshheading:16837570-Molecular Structure,
pubmed-meshheading:16837570-Propranolol,
pubmed-meshheading:16837570-Substrate Specificity
|
pubmed:year |
2006
|
pubmed:articleTitle |
Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine.
|
pubmed:affiliation |
Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, Kumamoto 862-0973, Japan. iteruko@gpo.kumamoto-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|